drugset / Trial / NCT00008034

Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer

NCT00008034

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells and shrink tumors so they can be removed during surgery. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy before surgery in treating women who have locally advanced, inflammatory, or large surgically removable breast cancer.

Timeline

Start
2000-02
Primary completion
2000-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule Oral
Subject Cyclophosphamide Other / unclassified Intravenous
Subject Epirubicin Small molecule Intravenous

Indications